Coronary calcium scoring shown to be cost-effective for stratifying risk and guiding statin therapy
Test Not Guess
Related Articles
Deep learning assists detection of esophageal cancer and precursor lesions in a prospective, randomized controlled study
A deep learning–based real-time detection system improves the detection rate of high-risk esophageal lesions.
Quiz of the Month – April 2024 – JBJS Clinical Classroom
The JBJS Quiz of the Month is a collection of 10 relevant questions from each orthopaedic subspecialty. The questions are drawn from JBJS Clinical Classroom,…
Ancient Female Ballplayer Makes Public Debut
The statue will be part of “Ancient Huasteca Women: Goddesses, Warriors and Governors” at the National Museum of Mexican Art in Chicago.
A haven no more: Women’s groups brace for Florida’s 6-week abortion ban
Out-of-state abortions will be more expensive, difficult to get for women across much of the South, advocates warn.
Cilta-cel Shows High Responses for Lenalidomide-Refractory Myeloma in First Relapse
The latest CARTITUDE-4 data examine the efficacy and safety of ciltacabtagene autoleucel in lenalidomide-refractory multiple myeloma.
Home Page: Deep Brain Stimulation
Deep Brain Stimulation is a peer-reviewed international journal covering all topics in the field of deep brain stimulation (DBS), both in clinical and basic science.…
WebMD Ignite launches new member engagement platform for payers
WebMD Ignite is launching a new suite of tech tools it says will help payers turbocharge their clinical programs. | WebMD Ignite is launching a…
Stress First Aid for Health Care Professionals
This toolkit explains the signs and effects of stress injuries on health care professionals. It explains how to administer Stress First Aid, a framework for…
Code Green: A podcast series
Listen to our Code Green podcast to hear insights from cyber leaders on the ways to combat threats within the life sciences and health care…
FAS signalling pathway is crucial for CAR T cell persistence
Nature Reviews Immunology – A preprint by Yi et al. shows a role for the FAS signalling pathway in controlling the persistence of CAR-modified lymphocytes.
